摘要
The global pandemic of the novel coronavirus disease (COVID-19) has increased the number of patients suffering from acute respiratory distress syndrome (ARDS), as well as the risk of opportunistic fungal infections and secondary infections. This review article mainly discusses the increase in mucormycosis, aspergillosis, and candidiasis infections associated with COVID-19. The main reasons appeared to be the use of respirators, excessive use of steroids, and diabetes. COVID-19 patients with fungal infections had a high morbidity and fatality rate thus early diagnosis and treatment was pivotal. For patients with risk factors, a combination of serological and molecular diagnostic techniques and treatment with antifungal drugs are used to reduce the risk of severe illness and death caused by complicated diseases.
延伸閱讀
- 洪家新（2021）。Impact of COVID-19 Epidemic on Overseas Travel Constraints and Negotiations for the Elderly〔碩士論文，國立臺灣師範大學〕。華藝線上圖書館。https://doi.org/10.6345/NTNU202101645
- Shen, L. (2022). Prevention and Control of the COVID-19 Virus. World Scientific Research Journal, 8(7), 301-305. https://doi.org/10.6911/WSRJ.202207_8(7).0042
- 李愛先、王嘉康、朱芳業、林子玉（2021）。Multiple and Efficient Strategies for COVID-19 Screening。台灣醫學，25(6)，778-787。https://doi.org/10.6320/FJM.202111_25(6).0009
- 賴榮斌（2021）。Intervention and prediction of the spread of Covid-19 infectious disease〔博士論文，國立暨南國際大學〕。華藝線上圖書館。https://doi.org/10.6837/ncnu202200013
- 孫意惟、江德祐、張闈墨（2022）。Oral Antiviral Treatments for COVID-19。彰化護理，29(2)，57-67。https://doi.org/10.6647/CN.202206_29(2).0010